Waiting for bleeding after Provera can make every day feel significant, especially when the tablets were prescribed before fertility treatment. After a short prescribed course of oral Provera for absent periods, a withdrawal bleed commonly starts about 3 to 7 days after the final tablet. Some people bleed sooner, later or not at all, and the exact window depends on the regimen and why it was prescribed.
The 3 to 7 day range is commonly cited in manufacturer prescribing information. Current Australian Product Information confirms short oral courses for secondary amenorrhoea and abnormal uterine bleeding, but it does not promise one exact post-treatment day. Follow the directions on your pack and the timeframe given by your prescriber.
Provera contains medroxyprogesterone acetate, a prescription progestogen. This article is about oral tablets, not the long-acting Depo-Provera contraceptive injection. If the expected bleeding window has passed, take a pregnancy test if pregnancy is possible and contact the prescriber. Do not restart the tablets, increase the dose or copy another person’s course.
Quick answers about a period after Provera
How long after Provera does a period start?
Many people begin a withdrawal bleed about 3 to 7 days after the last oral tablet. The exact timing can vary with the prescribed regimen, the uterine lining and the condition being treated.
What are the signs Provera is working?
When the treatment goal is to bring on a withdrawal bleed, bleeding after the course is the clearest intended response. Spotting or side effects do not prove treatment success, and a bleed does not confirm ovulation.
What should you do if no bleeding starts after Provera?
Take a pregnancy test if pregnancy is possible and contact the prescriber when their expected window has passed. Do not repeat the course, increase the dose or use leftover tablets without medical advice.
Why can Provera cause a withdrawal bleed?
During a natural ovulatory cycle, progesterone rises after an egg is released and then falls if pregnancy does not occur. That fall helps trigger menstruation. Oral medroxyprogesterone gives the uterine lining a progesterone-like signal for the prescribed number of days. When the course ends, the change in hormone exposure can prompt the endometrium to shed.
This is called a withdrawal bleed. It may look and feel like a period, but it was triggered by stopping the medicine rather than by proving that ovulation occurred. Understanding how oestrogen, progesterone, LH and FSH change across the menstrual cycle helps explain why the bleed can be useful without answering every fertility question.
A visible response is more likely when enough endometrium developed before the course and blood can leave the uterus normally. A very thin lining, low oestrogen exposure or scarring inside the uterus can change the response, which is why no bleeding needs interpretation rather than another unsupervised course.
Provera withdrawal bleed timeline: what to expect after your last tablet
Count from the last tablet, not the first. The most commonly cited window is about 3 to 7 days after stopping oral Provera. Reaching day 2 without bleeding is usually still early, and reaching day 8 does not by itself prove that the medicine failed.
| Timing | What may be happening | What to do |
|---|---|---|
| While taking the tablets | No bleeding, light spotting or breakthrough bleeding can occur. | Continue exactly as prescribed unless the clinician advises a change. |
| Days 1 to 2 | It may still be early for a withdrawal bleed. | Keep the final dose date recorded and monitor the pattern. |
| Days 3 to 7 | This is the commonly cited withdrawal-bleeding window. | Record the first day of full flow, amount, pain and dizziness. |
| After day 7 | A later response can occur, but pregnancy and the prescribed plan matter. | Check the deadline given by your prescriber and test for pregnancy if relevant. |
| No proper bleed by the advised checkpoint | Pregnancy, limited endometrial response or another hormonal or structural explanation may need assessment. | Contact the prescriber rather than repeating the course yourself. |
Your previous response to Provera provides context but does not create a fixed personal deadline. A course that produced bleeding after 4 days once may take longer another time. Missed tablets, a different regimen, pregnancy risk and changes in the underlying cycle can alter the timing.
What will your period be like after taking Provera?
The withdrawal bleed may begin with brown, pink or light red spotting before becoming a fuller flow. It can be lighter than your usual period, similar to it, heavier or more irregular. The amount partly reflects how much endometrium was present when the medicine was stopped.
There is no single bleeding duration that proves Provera worked. A typical menstrual period often lasts several days, but an individual withdrawal bleed may be shorter or longer. Keep spotting separate from full flow in your notes so the prescriber can see the pattern clearly.
Contact a clinician if bleeding continues beyond a week, is much heavier than normal, repeatedly stops and restarts or affects your daily activities. Seek urgent care if the bleeding suddenly becomes much heavier than usual or is accompanied by weakness, dizziness or faintness.
Common side effects and warning signs
Possible effects of oral Provera include headache, nausea or vomiting, dizziness, tiredness, sleep or mood changes, bloating or fluid retention, breast tenderness, spotting and irregular bleeding. Read the Consumer Medicine Information supplied with your pack because the prescribed dose, other medicines and your health history affect what advice applies.
Contact a doctor urgently or go to an emergency department for chest pain, sudden shortness of breath, painful swelling in an arm or leg, a severe headache with speech or vision changes, weakness or numbness, yellowing of the skin or eyes, or swelling of the face, lips or tongue with breathing difficulty.
Call triple zero on 000 for severe or life-threatening symptoms, including collapse, severe breathing difficulty or signs of a stroke. Sudden very heavy vaginal bleeding with marked weakness, dizziness or faintness also needs urgent assessment.
Signs Provera is working: what counts and what does not?
When Provera was prescribed to bring on bleeding, the clearest intended response is a withdrawal bleed after the course. Spotting during treatment, breast tenderness, bloating, headache, nausea or mood changes can occur, but these are not reliable signs that the treatment achieved its intended purpose.
What a Provera withdrawal bleed can and cannot tell you
It can support: that the endometrium responded to the change in progestogen exposure and that there was a pathway for bleeding to leave the uterus. It can also provide a practical date for a clinic-directed cycle plan.
It cannot confirm: that ovulation occurred, that the next cycle will ovulate, why periods stopped, whether the fallopian tubes are open, egg quality, overall fertility or whether pregnancy is impossible.
A withdrawal response is one piece of information, not a final diagnosis. Current specialist guidance recognises that progestogen-withdrawal responses can sometimes be misleading, so the result should be read with the history, pregnancy testing, hormone pattern and ultrasound findings when relevant.
No period after Provera: could you be pregnant?
Pregnancy is the first possibility to exclude when conception could have occurred. A urine result can be negative if testing was too early or the sample was dilute. When a fresh home test is appropriate, you can compare pregnancy tests and follow the instructions for the exact device. Contact the prescriber after a positive or unclear result.
If tests are negative and bleeding still does not start, the response can be affected by low oestrogen exposure or a lining that is too thin to shed noticeably. Functional hypothalamic amenorrhoea, premature ovarian insufficiency, perimenopause, thyroid disorders, raised prolactin, some medicines and polyendocrine metabolic ovarian syndrome, previously called PCOS, can all sit within the wider assessment.
A negative pregnancy test does not identify which explanation applies. The broader no period with a negative pregnancy test pathway can help you prepare the dates and symptoms that are most useful at a GP appointment.
Less commonly, scarring inside the uterine cavity or narrowing at the cervix can reduce or prevent bleeding. This is more relevant if periods became much lighter or stopped after uterine surgery, treatment of a pregnancy loss or a procedure such as dilation and curettage. The D&C recovery guide explains when a persistent change in bleeding should be discussed with a clinician.
What may an Australian GP or fertility specialist check next?
Take the medicine packet or a photo of the label, the prescribed dose, the first and last tablet dates, any missed doses, spotting, the first day of full flow and pregnancy-test results. The same medicine can be prescribed for different reasons, so the exact regimen matters.
A clinician may ask about your previous cycle pattern, recent weight or nutrition changes, exercise, stress, breastfeeding, hot flushes, acne, increased facial or body hair, nipple discharge, pelvic pain, other medicines and previous uterine procedures. These details decide which tests are useful rather than triggering one standard panel for everyone.
Depending on the history, assessment may include urine or blood hCG, thyroid-stimulating hormone, prolactin, FSH, LH and oestradiol. Androgen testing or metabolic assessment may be relevant when the wider PMOS fertility pattern is suspected. Pelvic ultrasound can add information about the uterus, endometrial thickness and ovaries when it would change management.
Trying to conceive after Provera
Provera is sometimes used to create a practical bleeding date before fertility investigations or prescribed ovulation treatment. It does not itself trigger an egg to be released. Do not start letrozole, clomifene or another cycle medicine simply because bleeding began unless your written plan tells you when and how to start.
Many fertility clinics use the first day of full menstrual flow as cycle day 1, but some apply a time-of-day cut-off or another protocol. Follow the clinic’s definition before arranging blood tests, ultrasound or treatment.
Once the clinician says home tracking is appropriate, ovulation tests can help identify a urinary LH rise. They do not prove that an egg was released, and irregular hormone patterns can make results harder to interpret. After a clear positive result, timing intercourse after an LH surge is more useful than continuing to test for a darker line.
A short oral Provera course should not be relied on as contraception. If you do not want to become pregnant, ask which method is suitable. If a pregnancy test becomes positive after treatment, do not take more tablets unless the prescriber specifically directs you to do so, and follow the first steps after a positive pregnancy test in Australia.
Frequently Asked Questions about Provera and Periods in Australia
Can bleeding start while you are still taking Provera?
Yes. Spotting or breakthrough bleeding can occur during a course. Keep taking the tablets exactly as prescribed unless your clinician advises a change, and contact them sooner if the bleeding is heavy, prolonged or accompanied by significant pain or dizziness.
How long can a Provera withdrawal bleed last?
Bleeding often lasts several days, but Provera does not create a fixed duration for every person. Start counting from full flow rather than initial spotting, and seek advice if it continues beyond a week or becomes progressively heavier.
Does spotting count as cycle day 1 after Provera?
Many fertility clinics count cycle day 1 as the first day of full menstrual flow rather than light spotting. Protocols and time cut-offs differ, so use the definition supplied by your clinic before starting tests, scans or treatment.
Can Provera make the first bleed heavier than usual?
Yes. The withdrawal bleed can be heavier, lighter or more irregular than your usual period. Seek urgent assessment if bleeding is rapidly soaking through period products or occurs with severe pain, weakness, dizziness or fainting.
Can you get pregnant after taking Provera?
Yes. Pregnancy is possible if ovulation occurs because a short oral Provera course should not be relied on as contraception. Ask your prescriber about contraception or conception timing for your situation.
Is oral Provera the same as Depo-Provera?
No. Oral Provera tablets may be prescribed for absent or abnormal bleeding. Depo-Provera is a long-acting contraceptive injection, so its dosing, bleeding pattern and return-to-fertility timeline are different.
Next Steps in Australia
Finish the prescribed course unless your clinician tells you to change it, then record the final tablet date and the first day of full bleeding. Keep spotting, flow, pain, dizziness and pregnancy-test results in the same note so the response can be reviewed accurately.
If no proper bleed has started by the checkpoint in your treatment plan, take a pregnancy test if pregnancy is possible and contact the prescriber. Do not repeat the course, increase the dose or use leftover tablets while waiting for advice.
Arrange a GP, gynaecology or fertility review when periods remain absent or very irregular, repeated courses are needed to create bleeding, or you are trying to conceive without a clear ovulation plan. The Australian fertility specialist pathway explains when referral may be useful. Take the packet, dosing dates, bleeding record and test results to the appointment so the next decision is based on your actual response.
Last reviewed: 5 September 2026
Next scheduled review: September 2027
References
Fertility2Family articles are researched using Australian Government health guidance, professional clinical recommendations and peer-reviewed medical literature. The references below were used to research and medically review this article and provide additional reading for readers who want to explore the evidence in more detail.
You can read how we research, write and check our health information in our editorial and medical review policy, and see who reviews our articles and their clinical credentials.
Australian Commission on Safety and Quality in Health Care. Provera
Current Australian Consumer Medicine Information for oral Provera, covering indications, prescribed use, pregnancy precautions, bleeding changes, common adverse effects and symptoms requiring urgent medical attention.
Pfizer Australia Pty Ltd. Australian Product Information: PROVERA (medroxyprogesterone acetate) tablets
Current Australian Product Information describing approved oral-tablet indications, regimen variation, contraindications, breakthrough bleeding, adverse effects and medroxyprogesterone action on an oestrogen-primed endometrium.
Pfizer. PROVERA
Current manufacturer prescribing information providing the commonly cited three-to-seven-day withdrawal-bleeding range after oral medroxyprogesterone is discontinued, alongside contraindications and adverse-effect information.
American Society for Reproductive Medicine. Current evaluation of amenorrhea: a committee opinion
Current specialist guidance on secondary amenorrhoea, pregnancy exclusion, endocrine testing, pelvic ultrasound and limitations of interpreting a progestogen withdrawal response when bleeding does not occur.
Healthdirect Australia. Irregular periods
Australian consumer guidance on irregular or absent bleeding, common hormonal and lifestyle causes, useful cycle records, clinical assessment and reasons to see a doctor.
Healthdirect Australia. Heavy periods (menorrhagia)
Australian guidance on recognising heavy menstrual bleeding, associated symptoms, medical assessment and situations in which sudden heavy bleeding with weakness or dizziness needs urgent care.
Pregnancy, Birth and Baby. Pregnancy tests
Australian guidance on urine and blood pregnancy testing, useful timing, early false-negative results, confirmation and when persistent uncertainty should be discussed with a health professional.
Pregnancy, Birth and Baby. Ovulation and fertility
Australian guidance on ovulation, the fertile window, urinary LH testing and the limits of using an ovulation predictor result to establish the exact time of egg release.
Monash Centre for Health Research and Implementation. PMOS Guideline and Resources
Current Australian-led evidence resources for polyendocrine metabolic ovarian syndrome, previously called PCOS, including ovulatory dysfunction, fertility considerations and evidence-based assessment and management.
The Royal Women’s Hospital. Depo Provera
Australian hospital guidance describing Depo-Provera as a long-acting contraceptive injection and explaining why its bleeding and return-to-fertility timeline differs from a short oral Provera course.
Australian Journal of General Practice. Assessment of female fertility in the general practice setting
Australian general-practice review covering cycle history, pregnancy exclusion, targeted hormone testing, pelvic ultrasound and fertility assessment when ovulation or menstrual regularity is uncertain.
NHS. Common questions about medroxyprogesterone tablets
National health guidance explaining cyclic oral medroxyprogesterone, bleeding after stopping treatment and why short-course medroxyprogesterone tablets should not be relied on as contraception.